State Street’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,294,807
Closed -$8.34M 4471
2023
Q4
$8.34M Buy
3,294,807
+355,455
+12% +$828K ﹤0.01% 2703
2023
Q3
$7.03M Sell
2,939,352
-12,979
-0.4% -$28.7K ﹤0.01% 2758
2023
Q2
$6.82M Buy
2,952,331
+40,876
+1% +$115K ﹤0.01% 2843
2023
Q1
$7.42M Buy
2,911,455
+94,231
+3% +$270K ﹤0.01% 2818
2022
Q4
$7.07M Buy
2,817,224
+48,268
+2% +$135K ﹤0.01% 2877
2022
Q3
$8.03M Buy
2,768,956
+258,449
+10% +$1.09M ﹤0.01% 2832
2022
Q2
$11.3M Buy
2,510,507
+2,012,256
+404% +$12M ﹤0.01% 2648
2022
Q1
$4M Buy
498,251
+57,051
+13% +$503K ﹤0.01% 3290
2021
Q4
$5.14M Buy
+441,200
New +$5.28M ﹤0.01% 3230

State Street's SLGC Position: Q1 2024 in Review

State Street sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 3,294,807 shares — an estimated $8.34M sold.

State Street first reported a position in SLGC in Q4 2021 and held it in 9 quarters. The position peaked at $11.3M in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • State Street reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • State Street sold 3,294,807 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $8.34M.
  • State Street first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 9 quarters.
  • State Street's SomaLogic, Inc. Class A Common Stock position peaked at $11.3M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.